Review



macrolide therapy  (Nagai Nori USA INC)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Nagai Nori USA INC macrolide therapy
    (Left) Dose-dependent effects of <t>macrolide</t> antibiotics on the release of NO from LPS-stimulated murine macrophages. The cells were incubated for 24 h with various concentrations of ERY (A) , RXT (B) , CLT (C) , and AZT (D) . Max doses (250 μM for ERY, RXT and AZT and 62.5 μM for CLT) were adjusted to achieve a cell viability ≥ 80%. Values on the vertical axe represent the percentage of control of NO formation in the culture medium after addition of LPS. (Right) Human in vitro liver microsome stabilities ( n = 3 per time point) for ERY (E) , RXT (F) , CLT (G) , and AZT (H) . Data are means ± STDEV; n = 6 for each concentration and time point.
    Macrolide Therapy, supplied by Nagai Nori USA INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/macrolide+therapy/macrolide+therapy/pmc05388737-245-8-26
    Average 90 stars, based on 1 article reviews
    macrolide therapy - by Bioz Stars, 2026-09
    90/100 stars

    Images

    1) Product Images from "Exploring the Role of CYP3A4 Mediated Drug Metabolism in the Pharmacological Modulation of Nitric Oxide Production"

    Article Title: Exploring the Role of CYP3A4 Mediated Drug Metabolism in the Pharmacological Modulation of Nitric Oxide Production

    Journal: Frontiers in Pharmacology

    doi: 10.3389/fphar.2017.00202

    (Left) Dose-dependent effects of macrolide antibiotics on the release of NO from LPS-stimulated murine macrophages. The cells were incubated for 24 h with various concentrations of ERY (A) , RXT (B) , CLT (C) , and AZT (D) . Max doses (250 μM for ERY, RXT and AZT and 62.5 μM for CLT) were adjusted to achieve a cell viability ≥ 80%. Values on the vertical axe represent the percentage of control of NO formation in the culture medium after addition of LPS. (Right) Human in vitro liver microsome stabilities ( n = 3 per time point) for ERY (E) , RXT (F) , CLT (G) , and AZT (H) . Data are means ± STDEV; n = 6 for each concentration and time point.
    Figure Legend Snippet: (Left) Dose-dependent effects of macrolide antibiotics on the release of NO from LPS-stimulated murine macrophages. The cells were incubated for 24 h with various concentrations of ERY (A) , RXT (B) , CLT (C) , and AZT (D) . Max doses (250 μM for ERY, RXT and AZT and 62.5 μM for CLT) were adjusted to achieve a cell viability ≥ 80%. Values on the vertical axe represent the percentage of control of NO formation in the culture medium after addition of LPS. (Right) Human in vitro liver microsome stabilities ( n = 3 per time point) for ERY (E) , RXT (F) , CLT (G) , and AZT (H) . Data are means ± STDEV; n = 6 for each concentration and time point.

    Techniques Used: Incubation, Control, In Vitro, Concentration Assay



    Similar Products

    macrolide therapy  (Wolters Kluwer Health)
    90
    Wolters Kluwer Health macrolide therapy
    Macrolide Therapy, supplied by Wolters Kluwer Health, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/macrolide+therapy/clinical+nuclear+medicine/10__1097_slash_inf__0000000000002703-160-11-2
    Average 90 stars, based on 1 article reviews
    macrolide therapy - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    maternal macrolide therapy  (Wolters Kluwer Health)
    90
    Wolters Kluwer Health maternal macrolide therapy
    Maternal Macrolide Therapy, supplied by Wolters Kluwer Health, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/macrolide+therapy/maternal+macrolide+therapy/10__1097_slash_inf__0000000000001994-82-9-18
    Average 90 stars, based on 1 article reviews
    maternal macrolide therapy - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    macrolide therapy  (Nagai Nori USA INC)
    90
    Nagai Nori USA INC macrolide therapy
    (Left) Dose-dependent effects of <t>macrolide</t> antibiotics on the release of NO from LPS-stimulated murine macrophages. The cells were incubated for 24 h with various concentrations of ERY (A) , RXT (B) , CLT (C) , and AZT (D) . Max doses (250 μM for ERY, RXT and AZT and 62.5 μM for CLT) were adjusted to achieve a cell viability ≥ 80%. Values on the vertical axe represent the percentage of control of NO formation in the culture medium after addition of LPS. (Right) Human in vitro liver microsome stabilities ( n = 3 per time point) for ERY (E) , RXT (F) , CLT (G) , and AZT (H) . Data are means ± STDEV; n = 6 for each concentration and time point.
    Macrolide Therapy, supplied by Nagai Nori USA INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/macrolide+therapy/macrolide+therapy/pmc05388737-245-8-26
    Average 90 stars, based on 1 article reviews
    macrolide therapy - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    macrolide therapy  (Kamada)
    90
    Kamada macrolide therapy
    Characteristics of studies included in meta-analysis of <t> macrolide </t> use in childhood asthma
    Macrolide Therapy, supplied by Kamada, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/macrolide+therapy/macrolides/pmc03549681-86-20-0
    Average 90 stars, based on 1 article reviews
    macrolide therapy - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    milestones in drug therapy: macrolide antibiotics  (Verlag GmbH)
    90
    Verlag GmbH milestones in drug therapy: macrolide antibiotics
    Characteristics of studies included in meta-analysis of <t> macrolide </t> use in childhood asthma
    Milestones In Drug Therapy: Macrolide Antibiotics, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/macrolide+therapy/macrolide+antibiotics/us07910558-39-4-7
    Average 90 stars, based on 1 article reviews
    milestones in drug therapy: macrolide antibiotics - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    4-week regimen of fluoroquinolone– macrolide combination therapy  (Blackwell Verlag)
    90
    Blackwell Verlag 4-week regimen of fluoroquinolone– macrolide combination therapy
    Characteristics of studies included in meta-analysis of <t> macrolide </t> use in childhood asthma
    4 Week Regimen Of Fluoroquinolone– Macrolide Combination Therapy, supplied by Blackwell Verlag, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/macrolide+therapy/4+week+regimen+of+fluoroquinolone++macrolide+combination+therapy/pm21105887-70-18-3
    Average 90 stars, based on 1 article reviews
    4-week regimen of fluoroquinolone– macrolide combination therapy - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    macrolide therapy  (Takeda)
    90
    Takeda macrolide therapy
    Characteristics of studies included in meta-analysis of <t> macrolide </t> use in childhood asthma
    Macrolide Therapy, supplied by Takeda, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/macrolide+therapy/macrolide+ring+system/pm18289694-94-8-16
    Average 90 stars, based on 1 article reviews
    macrolide therapy - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    macrolide therapy  (Tanabe)
    90
    Tanabe macrolide therapy
    Characteristics of studies included in meta-analysis of <t> macrolide </t> use in childhood asthma
    Macrolide Therapy, supplied by Tanabe, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/macrolide+therapy/macrolide+therapy/10__1157_slash_13108785-759-19-4
    Average 90 stars, based on 1 article reviews
    macrolide therapy - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    (Left) Dose-dependent effects of macrolide antibiotics on the release of NO from LPS-stimulated murine macrophages. The cells were incubated for 24 h with various concentrations of ERY (A) , RXT (B) , CLT (C) , and AZT (D) . Max doses (250 μM for ERY, RXT and AZT and 62.5 μM for CLT) were adjusted to achieve a cell viability ≥ 80%. Values on the vertical axe represent the percentage of control of NO formation in the culture medium after addition of LPS. (Right) Human in vitro liver microsome stabilities ( n = 3 per time point) for ERY (E) , RXT (F) , CLT (G) , and AZT (H) . Data are means ± STDEV; n = 6 for each concentration and time point.

    Journal: Frontiers in Pharmacology

    Article Title: Exploring the Role of CYP3A4 Mediated Drug Metabolism in the Pharmacological Modulation of Nitric Oxide Production

    doi: 10.3389/fphar.2017.00202

    Figure Lengend Snippet: (Left) Dose-dependent effects of macrolide antibiotics on the release of NO from LPS-stimulated murine macrophages. The cells were incubated for 24 h with various concentrations of ERY (A) , RXT (B) , CLT (C) , and AZT (D) . Max doses (250 μM for ERY, RXT and AZT and 62.5 μM for CLT) were adjusted to achieve a cell viability ≥ 80%. Values on the vertical axe represent the percentage of control of NO formation in the culture medium after addition of LPS. (Right) Human in vitro liver microsome stabilities ( n = 3 per time point) for ERY (E) , RXT (F) , CLT (G) , and AZT (H) . Data are means ± STDEV; n = 6 for each concentration and time point.

    Article Snippet: The characteristics of the clinical nonantimicrobial properties of macrolide therapy include effective doses that are much lower than the minimal inhibitory concentration (i.e., low-dose macrolide therapy) (Nagai et al., ; Fujii et al., ; Kudoh et al., ; Shitrit et al., ).

    Techniques: Incubation, Control, In Vitro, Concentration Assay

    Characteristics of studies included in meta-analysis of macrolide use in childhood asthma

    Journal: Journal of Asthma and Allergy

    Article Title: Utility of adjunctive macrolide therapy in treatment of children with asthma: a systematic review and meta-analysis

    doi: 10.2147/JAA.S38652

    Figure Lengend Snippet: Characteristics of studies included in meta-analysis of macrolide use in childhood asthma

    Article Snippet: Kamada et al studied 11 children, and found a statistically significant reduction in daily oral corticosteroid dosage for children receiving macrolide therapy when compared with a placebo group.

    Techniques:

    Changes in FEV 1 with addition of macrolide

    Journal: Journal of Asthma and Allergy

    Article Title: Utility of adjunctive macrolide therapy in treatment of children with asthma: a systematic review and meta-analysis

    doi: 10.2147/JAA.S38652

    Figure Lengend Snippet: Changes in FEV 1 with addition of macrolide

    Article Snippet: Kamada et al studied 11 children, and found a statistically significant reduction in daily oral corticosteroid dosage for children receiving macrolide therapy when compared with a placebo group.

    Techniques:

    Random effects model analysis of adjunctive macrolide use and FEV 1 change in children with asthma. Notes: Grouping by oral corticosteroid use. I 2 = 89.80, Q = 39.23, P < 0.002. Abbreviations: CI, confidence interval; FEV 1 , forced expiratory volume in one second.

    Journal: Journal of Asthma and Allergy

    Article Title: Utility of adjunctive macrolide therapy in treatment of children with asthma: a systematic review and meta-analysis

    doi: 10.2147/JAA.S38652

    Figure Lengend Snippet: Random effects model analysis of adjunctive macrolide use and FEV 1 change in children with asthma. Notes: Grouping by oral corticosteroid use. I 2 = 89.80, Q = 39.23, P < 0.002. Abbreviations: CI, confidence interval; FEV 1 , forced expiratory volume in one second.

    Article Snippet: Kamada et al studied 11 children, and found a statistically significant reduction in daily oral corticosteroid dosage for children receiving macrolide therapy when compared with a placebo group.

    Techniques:

    Changes in OCS dose with addition of macrolide

    Journal: Journal of Asthma and Allergy

    Article Title: Utility of adjunctive macrolide therapy in treatment of children with asthma: a systematic review and meta-analysis

    doi: 10.2147/JAA.S38652

    Figure Lengend Snippet: Changes in OCS dose with addition of macrolide

    Article Snippet: Kamada et al studied 11 children, and found a statistically significant reduction in daily oral corticosteroid dosage for children receiving macrolide therapy when compared with a placebo group.

    Techniques:

    Random effects model analysis of adjunctive macrolide use and oral steroid dose change in children with asthma. Notes: I 2 = 82.49, Q = 17.14, P < 0.05.

    Journal: Journal of Asthma and Allergy

    Article Title: Utility of adjunctive macrolide therapy in treatment of children with asthma: a systematic review and meta-analysis

    doi: 10.2147/JAA.S38652

    Figure Lengend Snippet: Random effects model analysis of adjunctive macrolide use and oral steroid dose change in children with asthma. Notes: I 2 = 82.49, Q = 17.14, P < 0.05.

    Article Snippet: Kamada et al studied 11 children, and found a statistically significant reduction in daily oral corticosteroid dosage for children receiving macrolide therapy when compared with a placebo group.

    Techniques: